Healthia (ASX:HLA) share price on watch after 78% profit growth

The share price of Healthia Ltd (ASX:HLA) will be on watch tomorrow after reporting profit growth of 78% in its FY21 half-year result.

The Healthia Ltd (ASX: HLA) share price will be on watch tomorrow after the healthcare business announced strong growth in its FY21 half-year result.

What did Healthia announce?

Healthia revealed that its customer revenue increased by 38.9% to $61.5 million. This revenue growth was supported by organic revenue growth of 14.5%.

Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) grew 90.7% to $11 million. The underlying EBITDA margin increased by 486 basis points to 17.87%.

Underlying net profit after tax plus amortisation of customer list intangibles (NPATA) jumped 85.5% to $4.7 million. The underlying NPATA margin increased 194 basis points to 7.72%.

The underlying earnings per share (EPS) grew 78.2% to 6.86 cents. The Healthia board of directors decided to declare an interim fully franked dividend of 2 cents per share.

Management said that this result is testament to the ongoing dedication and resilience of its clinicians and support staff. Healthia said the result was also reflective of the essential nature of the allied health services that its businesses and people provide to their local communities.

The company said that as it integrates its new 'eyes and ears' division, settled in November 2020, into its allied health network it will attempt to generate growth from cross-referrals between Healthia's three disciplines to promote better patient outcomes.

Recent Healthia share price movements

The Healthia share price has gone up by 33% over the last 12 months, despite the COVID-19  pandemic. Since the end of October 2020, Healthia shares have actually risen by 60%.

Outlook

Healthia said it will continue to focus on four areas: patient focused outcomes, organic growth, future accretive acquisitions and vertically integrated business units.

It has a few different strategies to generate ongoing organic growth. It said it will continue to invest in industry-leading education, tools and support for clinicians, as well as developing industry-leading career opportunities for all team members. This is expected to continue to drive strong organic growth into the future.

Other organic growth strategies could be to further enhance its centralised support functions to clinical teams, finding additional opportunities to co-locate services, introducing services into existing locations and working on new ways to engage its teams.

Healthia said that the acquisition of The Optical Company and the addition of optometry increases its total addressable revenue market from $6.5 billion to $9.8 billion. That breaks down to $2.7 billion in feet and ankles, $3.8 billion in bodies and minds and $3.3 billion in eyes and ears, with the parent company haing a market share of less than 1.5%.

The company said that with its low market share, and the fragmented nature of the target allied health industries it operates, acquisitions will continue to be a central pillar of the growth strategy.

Healthia expects to deploy a minimum of $20 million per annum into new allied health acquisitions. These are expected to be funded from a combination of bank debt, free cash flow and clinic class shares.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia has recommended HEALTHIA FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

A team of people giving the thumbs up sign.
Broker Notes

6 ASX 200 shares that scored broker upgrades amid the market sell-off

Brokers raised their ratings on IAG, Lynas Rare Earths, Sandfire Resources, and other shares.

Read more »

Happy wife holding her hands on her husband's shoulders while both look at a laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man stands in front of a chart with an arrow going down and slaps his forehead in frustration.
ASX Share Market News

ASX 200 mining shares smashed in major market sell-off

The ASX 200 fell 5.39% amid a mining sell-off, with BHP shares tumbling almost 13% last week.

Read more »

A woman weraing a stripy t-shirt winks as she points to the decorative gold crown on her head.
ASX Share Market News

CBA shares back on top of the ASX 200 as BHP dives 13% this week

CBA shares have rallied 9.5% over the past month whilst BHP tumbled 13% this week.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »